Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 37869 

temporarily schedule 5F–ADB, its 

isomers, esters, ethers, salts and salts of 

isomers, esters, and ethers into 

Schedule I pursuant to the temporary 

scheduling provisions of the CSA. 

Etizolam belongs to a class of 

substances known as benzodiazepines. 

Benzodiazepines produce central 

nervous system depression and are 

commonly used to treat insomnia, 

anxiety, and seizure disorders. Etizolam 

is currently prescribed in some 

countries to treat generalized anxiety 

disorder with depressive symptoms, but 

is not approved for medical use or 

controlled in the United States under 

the CSA. WHO reported that non-fatal 

intoxications that include cases of 

driving under the influence of drugs 

have been linked to etizolam. The ECDD 

at its 37th (2015 meeting reviewed 

etizolam and recommended that a 

critical review of etizolam is warranted. 

Pregabalin is an anticonvulsant-type 

drug used to treat pain generated from 

the nervous system. It is available as an 

oral capsule and oral solution and 

approved for medical use in the United 

States for the management of 

neuropathic pain associated with 

diabetic peripheral neuropathy, postherpetic neuralgia, and adjunctive 

therapy for partial onset seizures, 

fibromyalgia, and neuropathic pain 

associated with spinal cord injury. 

Although the mechanism of action of 

pregabalin is unknown, studies in 

animals suggest that binding to the 

nervous system tissues may be involved 

in its pain-relieving and anti-seizure 

effects. Pregabalin binds with high 

affinity to the alpha 2-delta receptor site 

(a subunit of voltage-gated calcium 

channels) in the central nervous system. 

The binding of pregabalin at this site is 

thought to be responsible for its 

therapeutic effect on neuropathic pain. 

Reports indicate that patients are selfadministering higher than 

recommended doses to achieve 

euphoria, especially patients who have 

a history of substance abuse, 

particularly opioids, and psychiatric 

illness. While effects of excessively high 

doses are generally non-lethal, 

gabapentinoids such as pregabalin are 

increasingly being identified in postmortem toxicology analyses. Pregabalin 

is a Schedule V controlled substance in 

the United States under the CSA. 

Tramadol is an opioid analgesic that 

produces its primary opioid-like action 

through an active metabolite referred to 

as the M1 metabolite (Odesmethyltramadol). Tramadol was first 

approved for marketing in the United 

States in 1995 and is available as 

immediate-release, extended-release, 

and combination products for the 

treatment of moderate to moderately 

severe pain. On July 2, 2014, the DEA 

published a final rule in the Federal 

Register controlling tramadol as a 

Schedule IV substance of the CSA 

effective from August 18, 2014. 

Tramadol was pre-reviewed by the 

ECDD at its 28th (1992) and 32nd (2000) 

meetings, and critically reviewed at the 

33rd (2002) meeting and not 

recommended for international control 

but placed on surveillance. Tramadol 

was pre-reviewed again by the ECDD at 

its 34th (2006) meeting; however, the 

ECDD concluded that there was not 

sufficient evidence to justify a critical 

review. At the 36th (2014) meeting, the 

ECDD considered updated information 

on tramadol, but again concluded that 

there was insufficient evidence to 

warrant a critical review. 

Cannabidiol (CBD) is one of the active 

cannabinoids identified in cannabis. 

CBD has been shown to be beneficial in 

experimental models of several 

neurological disorders, including those 

of seizure and epilepsy. In the United 

States, CBD-containing products are in 

human clinical testing in three 

therapeutic areas, but no such products 

are approved by FDA for marketing for 

medical purposes in the United States. 

CBD is a Schedule I controlled 

substance under the CSA. At the 37th 

(2015) meeting of the ECDD, the 

committee requested that the Secretariat 

prepare relevant documentation to 

conduct pre-reviews for several 

substances, including CBD. 

Ketamine is classified as a rapidacting general anesthetic agent used for 

short diagnostic and surgical procedures 

that do not require skeletal muscle 

relaxation. It is marketed in the United 

States as a solution for injection. 

Ketamine is controlled in Schedule III of 

the CSA in the United States. It is not 

controlled internationally under the 

Convention on Psychotropic Substances 

or the Single Convention on Narcotic 

Drugs. The ECDD reviewed ketamine at 

its 34th (2006), 35th (2012), and 36th 

(2014) meetings. On March 13, 2015, the 

Commission on Narcotic Drugs (CND) 

decided by consensus to postpone the 

consideration of a proposal concerning 

the recommendation to place ketamine 

in Schedule IV of the Psychotropic 

Convention. The CND requested 

additional information from the WHO. 

The ECDD reviewed updated 

information at its 37th (2015) meeting 

and found no reason to recommend a 

new pre-review or critical review of 

ketamine that could potentially change 

its standing 2014 recommendation that 

ketamine should not be placed under 

international control. 

IV. Opportunity To Submit Domestic 

Information 

As required by section 201(d)(2)(A) of 

the CSA, FDA, on behalf of HHS, invites 

interested persons to submit comments 

regarding the 17 named drug 

substances. Any comments received 

will be considered by HHS when it 

prepares a scientific and medical 

evaluation of these drug substances. 

HHS will forward a scientific and 

medical evaluation of these drug 

substances to WHO, through the 

Secretary of State, for WHO’s 

consideration in deciding whether to 

recommend international control/ 

decontrol of any of these drug 

substances. Such control could limit, 

among other things, the manufacture 

and distribution (import/export) of these 

drug substances and could impose 

certain recordkeeping requirements on 

them. 

Although FDA is, through this notice, 

requesting comments from interested 

persons, which will be considered by 

HHS when it prepares an evaluation of 

these drug substances, HHS will not 

now make any recommendations to 

WHO regarding whether any of these 

drugs should be subjected to 

international controls. Instead, HHS will 

defer such consideration until WHO has 

made official recommendations to the 

Commission on Narcotic Drugs, which 

are expected to be made in early 2018. 

Any HHS position regarding 

international control of these drug 

substances will be preceded by another 

Federal Register notice soliciting public 

comments, as required by section 

201(d)(2)(B) of the CSA. 

V. Electronic Access 

Persons with access to the Internet 

may obtain the document at either 

https://www.fda.gov/Drugs/Guidance

ComplianceRegulatoryInformation/ 

Guidances/default.htm or https://www.

regulations.gov. 

Dated: August 9, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–17119 Filed 8–11–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Division of Behavioral Health; Office of 

Clinical and Preventive Services; 

Behavioral Health Integration Initiative 

(BH2I) 

Announcement Type: New. 


sradovich on DSK3GMQ082PROD with NOTICES
37870 Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 

Funding Announcement Number: 

HHS–2017–IHS–BH2I–0001. 

Catalog of Federal Domestic 

Assistance Number: 93.933. 

Key Dates 

Application Deadline Date: 

September 16, 2017. 

Review Date: September 18, 2017. 

Earliest Anticipated Start Date: 

September 30, 2017. 

Signed Tribal Resolutions Due Date: 

September 16, 2017. 

Proof of Non-Profit Status Due Date: 

September 16, 2017. 

I. Funding Opportunity Description 

Statutory Authority 

The Indian Health Service (IHS) 

Office of Clinical and Preventative 

Services, Division of Behavioral Health, 

is accepting applications for its 

Behavioral Health Integration Initiative 

(Short Title: BH2I) to plan, develop, 

implement, and evaluate behavioral 

health integration with primary care, 

community based settings, and/or 

integrating primary care, nutrition, 

diabetes care, and chronic disease 

management with behavioral health. 

This program is authorized under: The 

Snyder Act, 25 U.S.C. 13, and 25 U.S.C. 

1665j. This program is described in the 

Catalog of Federal Domestic Assistance 

(CFDA) under 93.933. 

Background 

IHS supports changing the paradigm 

of mental health and substance use 

disorder services from being episodic, 

fragmented, specialty, and/or disease 

focused to incorporating it into the 

patient-centered home model. Research 

has shown that more than 70 percent of 

primary care visits stem from behavioral 

health issues. Depression is the most 

common type of mental illness, 

currently affecting more than a quarter 

of the U.S. adult population. With major 

depression currently the second leading 

cause of disability, it is clear that 

primary care settings have become an 

important access point for addressing 

both physical and behavioral health care 

needs. In addition, American Indian and 

Alaska Native (AI/AN) communities 

experience alarming rates of suicide, 

alcohol and drug-related deaths, 

domestic and sexual violence, and 

homicide. Describing the burden of 

trauma within any population is 

difficult, however indicators in terms of 

socially destructive behaviors are often 

used to illustrate this public health 

issue that creates impact through 

lifespan accumulation and chronic 

stress. Studies now indicate that 

resulting trauma from such events can 

even be passed from one generation to 

the next, resulting in intergenerational 

and historical trauma. While mental 

health needs can often go untreated and 

even unnoticed, the lasting effects of 

childhood trauma into adulthood is 

often evident in physical manifestations 

leading to negative health 

consequences. These extreme disparities 

highlight an urgent need for improving 

access to mental health services in 

primary care for children and families 

through the integration of behavioral 

health services, including traumainformed care, within primary care 

settings. In addition, recognizing that 

behavioral and physical health 

problems are interwoven, delivery of 

behavioral health services in primary 

care settings reduces stigma and 

discrimination, and the majority of 

people with behavioral health disorders 

treated within an integrated primary 

care setting have improved outcomes. 

Purpose 

The purpose of the Behavioral Health 

Integration Initiative (BH2I) grant 

opportunity is to improve the physical 

and mental health status of people with 

behavioral health issues by developing 

an integrative, coordinated system of 

care between behavioral health and 

primary care providers. This effort 

supports the IHS mission to raise the 

physical, mental, social and spiritual 

health of AI/ANs to the highest level. 

Increasing capacity among IHS, Tribal, 

and Urban Indian Organization (I/T/U) 

health facilities to implement an 

integrative approach in the delivery of 

behavioral health services, including 

trauma-informed care, nutrition, 

exercise, social, spiritual, cultural, and 

primary care services will improve 

morbidity and mortality outcomes 

among the AI/AN population. In 

addition, this effort will support 

activities that address improving the 

quality of life for individuals suffering 

from mental illness, substance use 

disorders, and adverse childhood 

experiences. Other outcomes related to 

this effort include improved behavioral 

health services that will increase access 

to integrated health and social wellbeing services and the early 

identification and intervention of 

mental health, substance use, and 

serious physical health issues, including 

chronic disease. This work will also 

identify and assess various models 

addressing unique integrative needs and 

the challenges, barriers and successes in 

AI/AN health systems. Finally, an 

improvement in the overall health of 

patients participating in integrative 

programs is expected. 

For this grant, the full spectrum of 

behavioral health services are strongly 

encouraged and are defined as: 

Screening for mental and substance use 

disorders, including serious mental 

illness; alcohol, substance, and opioid 

use disorders; suicidality and trauma 

(e.g., interpersonal violence, physical 

abuse, adverse childhood experiences) 

assessment, including risk assessment 

and diagnosis; patient-centered 

treatment planning, evidence based 

outpatient mental and substance use 

disorder treatment services (including 

pharmacological and psychosocial 

services); crisis services; peer support 

services; and care coordination. 

Models of Care 

IHS understands unique challenges 

and circumstances exist across Tribal 

communities and sites. In fact, 

integrative models of care vary 

according to needs and capabilities but 

all strive to enhance clinical processes 

and workflow across multi-disciplinary 

teams. This grant will support sites that 

have identified gaps in services and 

established efforts that moved toward 

linking those critical connections, 

including those with new and 

innovative ways of conducting business 

between differing management of 

operations between Federal and Tribal 

health services. 

II. Award Information 

Type of Award: Grant. 

Estimated Funds Available 

The total amount of funding 

identified for the current fiscal year (FY) 

2017 is approximately $6,000,000. 

Individual award amounts are 

anticipated to be $500,000. The amount 

of funding available for competing 

awards issued under this announcement 

are subject to the availability of 

appropriations and budgetary priorities 

of the agency. IHS is under no 

obligation to make awards that are 

selected for funding under this 

announcement. 

Anticipated Number of Awards 

Approximately 12 awards will be 

issued under this notice of funding 

opportunity announcement. 

Project Period 

The project period will be for three 

years and will run consecutively from 

September 30, 2017, to September 29, 

2020. 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 37871 

III. Eligibility Information 

I. 

1. Eligibility 

To be eligible for this New Funding 

Opportunity under this announcement, 

an applicant must be one of the 

following as defined by 25 U.S.C. 1603: 

• A Federally recognized Indian Tribe 

as defined by 25 U.S.C. 1603(14); 

• A Tribal organization as defined by 

25 U.S.C. 1603(26); 

• An Urban Indian organization as 

defined by 25 U.S.C. 1603(29); a 

nonprofit corporate body situated in an 

urban center, governed by an Urban 

Indian controlled board of directors, and 

providing for the maximum 

participation of all interested Indian 

groups and individuals, which body is 

capable of legally cooperating with 

other public and private entities for the 

purpose of performing the activities 

described in 25 U.S.C. 1653(a). 

Applicants must provide proof of nonprofit status with the application, e.g., 

501(c)(3). 

Note: Please refer to Section IV.2 

(Application and Submission Information/ 

Subsection 2, Content and Form of 

Application Submission) for additional proof 

of applicant status documents required, such 

as Tribal resolutions, proof of non-profit 

status, etc. 

2. Cost Sharing or Matching 

The IHS does not require matching 

funds or cost sharing for grants or 

cooperative agreements. 

3. Other Requirements 

If application budgets exceeds the 

award amount outlined under the 

‘‘Estimated Funds Available’’ section 

within this funding announcement, the 

application will be considered ineligible 

and will not be reviewed for further 

consideration. If deemed ineligible, IHS 

will not return the application. The 

applicant will be notified by email by 

the Division of Grants Management 

(DGM) of this decision. 

Tribal Resolution 

An Indian Tribe or Tribal organization 

that is proposing a project affecting 

another Indian Tribe must include 

Tribal resolutions from all affected 

Tribes to be served. Applications by 

Tribal organizations will not require a 

specific Tribal resolution if the current 

Tribal resolution(s) under which they 

operate would encompass the proposed 

grant activities. 

An official signed Tribal resolution 

must be received by the DGM prior to 

a Notice of Award (NoA) being issued 

to any applicant selected for funding. 

However, if an official signed Tribal 

resolution cannot be submitted with the 

electronic application submission prior 

to the official application deadline date, 

a draft Tribal resolution must be 

submitted by the deadline in order for 

the application to be considered 

complete and eligible for review. The 

draft Tribal resolution is not in lieu of 

the required signed resolution, but is 

acceptable until a signed resolution is 

received. If an official signed Tribal 

resolution is not received by DGM when 

funding decisions are made, then a 

Notice of Award will not be issued to 

that applicant and they will not receive 

any IHS funds until such time as they 

have submitted a signed resolution to 

the Grants Management Specialist listed 

in this Funding Announcement. 

Proof of Non-Profit Status 

Organizations claiming non-profit 

status must submit proof. A copy of the 

501(c)(3) Certificate must be received 

with the application submission by the 

Application Deadline Date listed under 

the Key Dates section on page one of 

this announcement. 

An applicant submitting any of the 

above additional documentation after 

the initial application submission due 

date is required to ensure the 

information was received by the IHS 

DGM by obtaining documentation 

confirming delivery (i.e., FedEx 

tracking, postal return receipt, etc.). 

IV. Application and Submission 

Information 

1. Obtaining Application Materials 

The application package and detailed 

instructions for this announcement can 

be found at http://www.Grants.gov or 

http://www.ihs.gov/dgm/funding/. 

Questions regarding the electronic 

application process may be directed to 

Mr. Paul Gettys at (301) 443–2114 or 

(301) 443–5204. 

2. Content and Form Application 

Submission 

The applicant must include the 

project narrative as an attachment to the 

application package. Mandatory 

documents for all applicants include: 

• Table of contents. 

• Abstract (one page) summarizing 

the project. 

• Application forms: 

Æ SF–424, Application for Federal 

Assistance. 

Æ SF–424A, Budget Information— 

Non-Construction Programs. 

Æ SF–424B, Assurances—NonConstruction Programs. 

• Project Narrative (must be singlespaced and not exceed 12 pages). 

Æ Statement of need, program 

planning and implementation approach, 

staff and organizational capacity, 

performance assessment and data, and 

evaluation plan. 

• Budget, Budget Justification and 

Narrative (must be single-spaced and 

not exceed four pages). 

• Tribal Resolution(s). 

• Letter(s) of Support: 

Æ For all applicants: Local 

organizational partners; 

Æ For all applicants: Community 

partners; 

Æ For Tribal organizations and UIOs: 

From the board of directors (or relevant 

equivalent); 

• 501(c)(3) Certificate (if applicable). 

• Biographical sketches for all Key 

Personnel (e.g., project coordinator etc.). 

• Contractor/Consultant resumes or 

qualifications and scope of work. 

• Disclosure of Lobbying Activities 

(SF–LLL). 

• Certification Regarding Lobbying 

(GG-Lobbying Form). 

• Copy of current Negotiated Indirect 

Cost rate (IDC) agreement (required in 

order to receive IDC). 

• Organizational Chart (optional). 

• Documentation of current Office of 

Management and Budget (OMB) 

Financial Audit (if applicable). 

Acceptable forms of documentation 

include: 

Æ Email confirmation from Federal 

Audit Clearinghouse (FAC) that audits 

were submitted; or 

Æ Face sheets from audit reports. 

These can be found on the FAC Web 

site: https://harvester.census.gov/ 

facdissem/Main.aspx. 

Public Policy Requirements 

All Federal-wide public policies 

apply to IHS grants and cooperative 

agreements with exception of the 

Discrimination policy. 

Requirements for Project and Budget 

Narratives 

A. Project Narrative (12 pages) 

The project narrative (Parts A through 

E listed below) should be in a separate 

Word document that should not exceed 

12 pages and must: Be single-spaced, 

type written, have consecutively 

numbered pages, use black type not 

smaller than 12 points, and be printed 

on one side only of standard size 81⁄2′′ 

x 11′′ paper. 

Be sure to succinctly address all items 

listed under the evaluation criteria 

section (refer to Section V.1, Evaluation 

criteria in this announcement) and place 

all responses and required information 

in the correct section (noted below), or 

they will not be considered or scored. 

These narratives will assist the 

Objective Review Committee (ORC) in 


sradovich on DSK3GMQ082PROD with NOTICES
37872 Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 

becoming familiar with the applicant’s 

activities and accomplishments prior to 

this possible grant award. If the 

narrative exceeds the page limit, only 

the first 12 pages will be reviewed. The 

12-page limit for the narrative does not 

include the table of contents, abstract, 

standard forms, Tribal resolutions, 

budget, budget justification narrative, 

and/or other appendix items. 

There are five (5) parts to the project 

narrative: 

Part A—Statement of Need; 

Part B—Program Planning and 

Implementation Approach; 

Part C—Staff and Organization 

Capacity; 

Part D—Performance Assessment and 

Data; and 

Part E—Evaluation Plan. 

Below are additional details about 

what must be included in the project 

narrative. 

Part A: Statement of Need (2 pages) 

The statement of need describes the 

current situation in the applicant’s 

Tribal community (‘‘community’’ means 

the applicant’s Tribe, village, Tribal 

organization, or consortium of Tribes or 

Tribal organizations). The statement of 

need provides the facts and evidence 

that support the need for the project and 

establishes that the Tribe, Tribal 

organization, or UIO understands the 

problems and can reasonably address 

them. The statement of need must not 

exceed two single-spaced pages. 

• Describe the community and 

priority population for your program 

including the patients or participants 

that you expect to serve and the reasons 

integrated behavioral health and 

primary care services are needed. 

• Describe current behavioral health 

and/or primary care services in place 

along with challenges and gaps to 

provide integrated behavioral health/ 

primary care services to individuals. 

• Explain how the BH2I can improve 

or enhance the current systems in place. 

Part B: Program Planning and 

Implementation Approach (5 pages) 

• State the purpose, goals and 

objectives of your proposed project. 

• Describe evidence-based programs, 

services or practices proposed for 

implementation, or will continue 

implementation through support of this 

grant opportunity. 

• Describe your current level of 

behavioral health integration (using the 

SAMHSA–HRSA Center for Integrated 

Health Solutions six-level framework 

(http://www.integration.samhsa.gov/ 

integrated-care-models/A_Standard_

Framework_for_Levels_of_Integrated_

Healthcare.pdf) and forecast how you 

will progress to higher levels of health 

integration. 

• Describe your plan to formally 

integrate behavioral health through: 

Æ Improving workflow in the 

assessment of behavioral health in 

primary care such as screenings, 

referral, and policy development. 

Æ Health information technology 

changes or improvements that facilitate 

behavioral health integration 

Æ Improving physical environment 

barriers in the delivery of integrated 

health care 

Æ Cross training staff, including 

psycho-education training for staff 

within primary care settings and basic 

medical education for behavioral health 

staff. 

Æ Establishing formal and informal 

channels of communication that 

facilitates behavioral health integration. 

Æ Describe how you will identify 

those individuals during the screening 

process who may indicate opioid and/ 

or alcohol use disorders and how you 

will refer them to Medication-Assisted 

Treatment (MAT)-qualified specialty 

treatment providers. 

Part C: Staff and Organization Capacity 

(2 pages) 

This section should describe 

applicant agency organization and 

structure and the capabilities possessed 

to complete proposed activities. This 

grant opportunity will focus on 

applicants and the applicant’s ability to 

implement a formalized integration plan 

focused on the enhancing the clinical 

processes for patient care among the IHS 

service areas. 

• Identify qualified professionals who 

will implement proposed grant 

activities, administer the grant, 

including progress and financial reports 

or provide salary costs for the addition 

of full-time equivalent (FTE) licensed 

behavioral health provider(s). 

• Describe the organization’s current 

system of providing at least one service 

of primary care and/or behavioral 

health, including screening, assessment, 

and care management. The primary 

applicant must directly deliver, operate, 

and/or manage at least one portion of 

direct primary care or behavioral health 

treatment services. 

• Describe the organization’s plan to 

hire full-time equivalent (FTE) licensed 

behavioral health provider(s). 

Part D: Performance Assessment and 

Data (2 pages) 

This section of the application should 

describe efforts to collect and report 

project data that will support and 

demonstrate BH2I activities. BH2I 

grantees will be required to collect and 

report data pertaining to activities, 

processes and outcomes. Data collection 

activities should capture and document 

actions conducted throughout awarded 

years including those that will 

contribute relevant project impact. 

• Describe specific data collection 

efforts that will be required as part of 

the EBP, or proposed evidence-based 

projects. 

• Describe data collection process 

and workflow that will assist in 

completing progress and evaluation 

requirements. 

• Explain proposed efforts to utilize 

health technology including 

accessibility, collection and monitoring 

of relevant data for proposed BH2I 

project. 

Part E: Evaluation Plan (1 page) 

The evaluation section should 

describe applicant’s plan to evaluate 

program activities. The evaluation plan 

should describe expected results and 

any identified metrics to support 

program effectiveness. Evaluation plans 

should incorporate questions related to 

outcomes and process including 

documentation of lessons learned. 

• Describe proposed evaluation 

methods including performance 

measures and other data relevant to 

evaluation outcomes including intended 

results (i.e., impact and outcomes), 

including any partners who will 

conduct evaluation if separate from the 

primary applicant. 

• Describe efforts to monitor 

improvements through the evaluation of 

increased coordination of care, colocated care, and integrated care with 

reference to the SAMHSA–HRSA Center 

for Integrated Health Solutions 

framework at http://

www.integration.samhsa.gov/integratedcare-models/CIHS_Framework_Final_

charts.pdf. 

B. Budget Narrative (4 pages) 

This narrative must include a line 

item budget with a narrative 

justification for all expenditures 

identifying reasonable allowable, 

allocable costs necessary to accomplish 

the goals and objectives as outlined in 

the project narrative. Budget should 

match the scope of work described in 

the project narrative. The budget and 

budget narrative should not exceed 4 

pages. 

3. Submission Dates and Times 

Applications must be submitted 

electronically through Grants.gov by 

11:59 p.m. Eastern Daylight Time (EDT) 

on the Application Deadline Date listed 

in the Key Dates section on page one of 

this announcement. Any application 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 37873 

received after the application deadline 

will not be accepted for processing, nor 

will it be given further consideration for 

funding. Grants.gov will notify the 

applicant via email if the application is 

rejected. 

If technical challenges arise and 

assistance is required with the 

electronic application process, contact 

Grants.gov Customer Support via email 

to support@grants.gov or at (800) 518– 

4726. Customer Support is available to 

address questions 24 hours a day, 7 days 

a week (except on Federal holidays). If 

problems persist, contact Mr. Gettys 

(Paul.Gettys@ihs.gov), DGM Grant 

Systems Coordinator, by telephone at 

(301) 443–2114 or (301) 443–5204. 

Please be sure to contact Mr. Gettys at 

least ten days prior to the application 

deadline. Please do not contact the DGM 

until you have received a Grants.gov 

tracking number. In the event you are 

not able to obtain a tracking number, 

call the DGM as soon as possible. 

4. Intergovernmental Review 

Executive Order 12372 requiring 

intergovernmental review is not 

applicable to this program. 

5. Funding Restrictions 

• Pre-award costs are not allowable. 

• The available funds are inclusive of 

direct and appropriate indirect costs. 

• Only one grant/cooperative 

agreement will be awarded per 

applicant. 

• IHS will not acknowledge receipt of 

applications. 

6. Electronic Submission Requirements 

All applications must be submitted 

electronically. Please use the http://

www.Grants.gov Web site to submit an 

application electronically and select the 

‘‘Find Grant Opportunities’’ link on the 

homepage. Follow the instructions for 

submitting an application under the 

Package tab. Electronic copies of the 

application may not be submitted as 

attachments to email messages 

addressed to IHS employees or offices. 

If the applicant needs to submit a 

paper application instead of submitting 

electronically through Grants.gov, a 

waiver must be requested. Prior 

approval must be requested and 

obtained from Mr. Robert Tarwater, 

Director, DGM, (see Section IV.6 below 

for additional information). A written 

waiver request must be sent to 

GrantsPolicy@ihs.gov with a copy to 

Robert.Tarwater@ihs.gov. The waiver 

must: (1) Be documented in writing 

(emails are acceptable), before 

submitting a paper application, and (2) 

include clear justification for the need 

to deviate from the required electronic 

grants submission process. 

Once the waiver request has been 

approved, the applicant will receive a 

confirmation of approval email 

containing submission instructions and 

the mailing address to submit the 

application. A copy of the written 

approval must be submitted along with 

the hardcopy of the application that is 

mailed to DGM. Paper applications that 

are submitted without a copy of the 

signed waiver from the Director of the 

DGM will not be reviewed or considered 

for funding. The applicant will be 

notified via email of this decision by the 

Grants Management Officer of the DGM. 

Paper applications must be received by 

the DGM no later than 5:00 p.m., EDT, 

on the Application Deadline Date listed 

in the Key Dates section on page one of 

this announcement. Late applications 

will not be accepted for processing or 

considered for funding. Applicants that 

do not adhere to the timelines for 

System for Award Management (SAM) 

and/or http://www.Grants.gov 

registration or that fail to request timely 

assistance with technical issues will not 

be considered for a waiver to submit a 

paper application. 

Please be aware of the following: 

• Please search for the application 

package in http://www.Grants.gov by 

entering the CFDA number or the 

Funding Opportunity Number. Both 

numbers are located in the header of 

this announcement. 

• If you experience technical 

challenges while submitting your 

application electronically, please 

contact Grants.gov Support directly at: 

support@grants.gov or (800) 518–4726. 

Customer Support is available to 

address questions 24 hours a day, 7 days 

a week (except on Federal holidays). 

• Upon contacting Grants.gov, obtain 

a tracking number as proof of contact. 

The tracking number is helpful if there 

are technical issues that cannot be 

resolved and a waiver from the agency 

must be obtained. 

• Applicants are strongly encouraged 

not to wait until the deadline date to 

begin the application process through 

Grants.gov as the registration process for 

SAM and Grants.gov could take up to 

fifteen working days. 

• Please use the optional attachment 

feature in Grants.gov to attach 

additional documentation that may be 

requested by the DGM. 

• All applicants must comply with 

any page limitation requirements 

described in this funding 

announcement. 

• After electronically submitting the 

application, the applicant will receive 

an automatic acknowledgment from 

Grants.gov that contains a Grants.gov 

tracking number. The DGM will 

download the application from 

Grants.gov and provide necessary copies 

to the appropriate agency officials. 

Neither the DGM nor the DBH will 

notify the applicant that the application 

has been received. 

• Email applications will not be 

accepted under this announcement. 

Dun and Bradstreet (D&B) Data 

Universal Numbering System (DUNS) 

All IHS applicants and grantee 

organizations are required to obtain a 

DUNS number and maintain an active 

registration in the SAM database. The 

DUNS number is a unique 9-digit 

identification number provided by D&B 

which uniquely identifies each entity. 

The DUNS number is site specific; 

therefore, each distinct performance site 

may be assigned a DUNS number. 

Obtaining a DUNS number is easy, and 

there is no charge. To obtain a DUNS 

number, you may access it through 

http://fedgov.dnb.com/webform, or to 

expedite the process, call (866) 705– 

5711. 

All HHS recipients are required by the 

Federal Funding Accountability and 

Transparency Act of 2006, as amended 

(‘‘Transparency Act’’), to report 

information on sub-awards. 

Accordingly, all IHS grantees must 

notify potential first-tier sub-recipients 

that no entity may receive a first-tier 

sub-award unless the entity has 

provided its DUNS number to the prime 

grantee organization. This requirement 

ensures the use of a universal identifier 

to enhance the quality of information 

available to the public pursuant to the 

Transparency Act. 

System for Award Management (SAM) 

Organizations that were not registered 

with Central Contractor Registration and 

have not registered with SAM will need 

to obtain a DUNS number first and then 

access the SAM online registration 

through the SAM home page at https:// 

www.sam.gov (U.S. organizations will 

also need to provide an Employer 

Identification Number from the Internal 

Revenue Service that may take an 

additional 2–5 weeks to become active). 

Completing and submitting the 

registration takes approximately one 

hour to complete and SAM registration 

will take 3–5 business days to process. 

Registration with the SAM is free of 

charge. Applicants may register online 

at https://www.sam.gov. 

Additional information on 

implementing the Transparency Act, 

including the specific requirements for 

DUNS and SAM, can be found on the 

IHS Grants Management, Grants Policy 


sradovich on DSK3GMQ082PROD with NOTICES
37874 Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 

Web site: http://www.ihs.gov/dgm/ 

policytopics/. 

V. Application Review Information 

The instructions for preparing the 

application narrative also constitute the 

evaluation criteria for reviewing and 

scoring the application. Weights 

assigned to each section are noted in 

parentheses. The 12 page project 

narrative should include only the first 

budget year of activities; information for 

multi-year projects should be included 

as an appendix. See ‘‘Multi-year Project 

Requirements’’ at the end of this section 

for more information. The narrative 

section should be written in a manner 

that is clear to outside reviewers 

unfamiliar with prior related activities 

of the applicant. It should be well 

organized, succinct, and contain all 

information necessary for reviewers to 

understand the project fully. Points will 

be assigned to each evaluation criteria 

adding up to a total of 100 points. A 

minimum score of 65 points is required 

for funding. Points are assigned as 

follows: 

1. Evaluation Criteria 

Applications will be reviewed and 

scored according to the quality of 

responses to the required application 

components in Sections A–F outlined 

below. In developing the required 

sections of this application, use the 

instructions provided for each section, 

which have been tailored to this 

program. The application must use the 

six sections (Sections A–F) in 

developing the application. The 

applicant must place the required 

information in the correct section or it 

will not be considered for review. The 

application will be scored according to 

how well the applicant addresses the 

requirements for each section listed 

below. The number of points after each 

section heading is the maximum 

number of points the review committee 

may assign to that section. Although 

scoring weights are not assigned to 

individual bullets, each bullet is 

assessed deriving the overall section 

score. 

A. Statement of Need (25 points) 

• The degree to which the applicant’s 

description of the service area/target 

population demonstrates the need for 

new/increased integrated primary 

health care/behavioral health services. 

• How well the applicant describes 

the unique characteristics of the service 

area and population that impact access 

to or utilization of behavioral health 

care. 

• How well the applicant describes 

existing behavioral health care 

providers in the service area, including 

identified gaps in behavioral health care 

services that the applicant can address 

via BH2I funds. 

B. Program Planning and 

Implementation Approach (25 points) 

• The degree to which the applicant’s 

purpose, goals and objectives of 

proposed project will address the 

mental and physical health needs 

through integrated an approach between 

primary health care/behavioral health 

services. 

• How well the applicant describes 

the evidence-based practices, practicebased evidence, promising practices and 

intervention efforts, including culturally 

appropriate services and interventions, 

to produce meaning and relevant results 

including additional detail to support 

evidence of effectiveness will support 

proposed project. 

• How well the applicant describes 

their current level of behavioral health 

integration (using the SAMHSA–HRSA 

Center for Integrated Health Solutions 

framework at http://

www.integration.samhsa.gov/integratedcare-models/CIHS_Framework_Final_

charts.pdf) and forecasts how they will 

progress to higher levels of health 

integration. 

• How well the applicant describe 

their plan to formally integrate 

behavioral health through: 

Æ Improving workflow in the 

assessment of behavioral health in 

primary care such as screenings, 

referral, and policy development. 

Æ Health information technology 

changes or improvements that facilitate 

behavioral health integration. 

Æ Improving physical environment 

barriers in the delivery of integrated 

health care. 

Æ Cross training staff, including 

psycho-education training for staff 

within primary care settings and basic 

medical education for behavioral health 

staff. 

Æ Establishing formal and informal 

channels of communication that 

facilitates behavioral health integration. 

Æ How well the applicant describes 

how they will identify those individuals 

during the screening process who may 

indicate opioid and/or alcohol use 

disorders and how they will refer them 

to Medication-Assisted Treatment 

(MAT)-qualified specialty treatment 

providers. 

C. Staff and Organizational Capacity (20 

points) 

• The degree to which the applicant 

describes the organization’s current 

system of providing at least one service 

of primary care and/or behavioral 

health, including screening, assessment, 

and care management. Does the 

applicant directly deliver, operate, and/ 

or manage at least one portion of direct 

primary care or behavioral health 

treatment services? 

• How well does the applicant 

identify qualified professionals who 

will implement proposed grant 

activities, administer the grant, 

including completion and submission of 

progress and financial reports, and how 

project continuity will be maintained if/ 

when there is a change in the 

operational environment (e.g., staff 

turnover, change in project leadership) 

to ensure project stability over the life 

of the grant. 

• The degree to which the applicant 

describes the organization’s plan to hire 

full-time equivalent (FTE) licensed 

behavioral health provider(s). 

• For individuals that are identified 

and currently on staff, include a 

biographical sketch for the project 

director, project coordinator, and other 

key positions as attachments to the 

project proposal/application. Each 

biographical sketch should not exceed 

one page. [Note: Attachments will not 

count against the 12 page maximum]. 

Do not include any of the following: 

D Personally Identifiable Information; 

D Resumes; or 

D Curriculum Vitae. 

D. Performance Assessment & Data (10 

points) 

• How well does the applicant 

describe plans for data collection, 

management, analysis and reporting for 

integration activities. 

• The degree to which the applicant 

lists expected data collection efforts that 

will be required as part of the EBP, or 

proposed evidence-based projects. 

• How well does the applicant 

explain proposed efforts to utilize 

health information technology including 

accessibility, collection and monitoring 

of relevant data for proposed BH2I 

project. 

• The degree to which the applicant 

discusses evaluation methods 

(including expertise and tools) that will 

be used to assess impacts and outcomes. 

E. Evaluation Plan (10 points) 

• How well did the applicant propose 

methods including quantitative and 

qualitative tools and resources, 

including techniques that will be 

utilized to measure outcomes, and 

partners who will conduct evaluation if 

separate from the primary applicant. 

• The degree to which the applicant 

describes performance measures and 

other data relevant to evaluation 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 37875 

outcomes including intended results 

(i.e., impact and outcomes). 

• The degree to which the applicant 

discusses how expected results will be 

measured (define indicators or measures 

that will be used to monitor and 

measure progress). 

• The degree to which the applicant 

describes a plan to monitor 

improvements through the evaluation of 

increased coordinated care, co-located 

care, and integrated care using the 

SAMHSA–HRSA Center for Integrated 

Health Solutions six-level framework 

(http://www.integration.samhsa.gov/ 

integrated-care-models/A_Standard_

Framework_for_Levels_of_Integrated_

Healthcare.pdf.) 

F. Categorical Budget and Budget 

Justification (10 points) 

This narrative must include a line 

item budget with a narrative 

justification for all expenditures 

identifying reasonable allowable, 

allocable costs necessary to accomplish 

the goals and objectives as outlined in 

the project narrative. Budget should 

match the scope of work described in 

the project narrative. The budget and 

budget narrative should not exceed 4 

pages. 

Multi-Year Project Requirements 

Projects requiring a second and third 

year must include a brief project 

narrative and budget (one additional 

page per year) addressing the 

developmental plans for each additional 

year of the project. 

Additional Documents Can Be 

Uploaded as Appendix Items in 

Grants.gov 

• Work plan, logic model and/or time 

line for proposed objectives. 

• Position descriptions for key staff. 

• Resumes of key staff that reflect 

current duties. 

• Consultant or contractor proposed 

scope of work and letter of commitment 

(if applicable). 

• Current Indirect Cost Agreement. 

• Organizational chart. 

• Map of area identifying project 

location(s). 

• Additional documents to support 

narrative (i.e. data tables, key news 

articles, etc.). 

2. Review and Selection 

Each application will be prescreened 

by the DGM staff for eligibility and 

completeness as outlined in the funding 

announcement. Applications that meet 

the eligibility criteria shall be reviewed 

for merit by the ORC based on 

evaluation criteria in this funding 

announcement. The ORC could be 

composed of both Tribal and Federal 

reviewers appointed by the IHS Program 

to review and make recommendations 

on these applications. The technical 

review process ensures selection of 

quality projects in a national 

competition for limited funding. 

Incomplete applications and 

applications that are non-responsive to 

the eligibility criteria will not be 

referred to the ORC. The applicant will 

be notified via email of this decision by 

the Grants Management Officer of the 

DGM. Applicants will be notified by 

DGM, via email, to outline minor 

missing components (i.e., budget 

narratives, audit documentation, key 

contact form) needed for an otherwise 

complete application. All missing 

documents must be sent to DGM on or 

before the due date listed in the email 

of notification of missing documents 

required. 

To obtain a minimum score for 

funding by the ORC, applicants must 

address all program requirements and 

provide all required documentation. 

VI. Award Administration Information 

1. Award Notices 

The NoA is a legally binding 

document signed by the Grants 

Management Officer and serves as the 

official notification of the grant award. 

The NoA will be initiated by the DGM 

in our grant system, GrantSolutions 

(https://www.grantsolutions.gov). Each 

entity that is approved for funding 

under this announcement will need to 

request or have a user account in 

GrantSolutions in order to retrieve their 

NoA. The NoA is the authorizing 

document for which funds are dispersed 

to the approved entities and reflects the 

amount of Federal funds awarded, the 

purpose of the grant, the terms and 

conditions of the award, the effective 

date of the award, and the budget/ 

project period. 

Disapproved Applicants 

Applicants who received a score less 

than the recommended funding level for 

approval, 65 points, and were deemed 

to be disapproved by the ORC, will 

receive an Executive Summary 

Statement from the IHS program office 

within 30 days of the conclusion of the 

ORC outlining the strengths and 

weaknesses of their application. The 

summary statement will be sent to the 

Authorized Organizational 

Representative that is identified on the 

face page (SF–424) of the application. 

The IHS program office will also 

provide additional contact information 

as needed to address questions and 

concerns as well as provide technical 

assistance if desired. 

Approved But Unfunded Applicants 

Approved but unfunded applicants 

that met the minimum scoring range 

and were deemed by the ORC to be 

‘‘Approved,’’ but were not funded due 

to lack of funding, will have their 

applications held by DGM for a period 

of one year. If additional funding 

becomes available during the course of 

FY 2017 the approved but unfunded 

application may be re-considered by the 

awarding program office for possible 

funding. The applicant will also receive 

an Executive Summary Statement from 

the IHS program office within 30 days 

of the conclusion of the ORC. 

Note: Any correspondence other than the 

official NoA signed by an IHS grants 

management official announcing to the 

project director that an award has been made 

to their organization is not an authorization 

to implement their program on behalf of IHS. 

2. Administrative Requirements 

Grants are administered in accordance 

with the following regulations and 

policies: 

A. The criteria as outlined in this 

program announcement. 

B. Administrative Regulations for 

Grants: 

• Uniform Administrative 

Requirements for HHS Awards, located 

at 45 CFR part 75. 

C. Grants Policy: 

• HHS Grants Policy Statement, 

Revised 01/07. 

D. Cost Principles: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Cost 

Principles,’’ located at 45 CFR part 75, 

subpart E. 

E. Audit Requirements: 

• Uniform Administrative 

Requirements for HHS Awards, ‘‘Audit 

Requirements,’’ located at 45 CFR part 

75, subpart F. 

3. Indirect Costs 

This section applies to all grant 

recipients that request reimbursement of 

indirect costs (IDC) in their grant 

application. In accordance with HHS 

Grants Policy Statement, Part II–27, IHS 

requires applicants to obtain a current 

IDC rate agreement prior to award. The 

rate agreement must be prepared in 

accordance with the applicable cost 

principles and guidance as provided by 

the cognizant agency or office. A current 

rate covers the applicable grant 

activities under the current award’s 

budget period. If the current rate is not 

on file with the DGM at the time of 

award, the IDC portion of the budget 

will be restricted. The restrictions 


sradovich on DSK3GMQ082PROD with NOTICES
37876 Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 

remain in place until the current rate is 

provided to the DGM. 

Generally, IDC rates for IHS grantees 

are negotiated with the Division of Cost 

Allocation (DCA) https://rates.psc.gov/ 

and the Department of Interior (Interior 

Business Center) https://www.doi.gov/ 

ibc/services/finance/indirect-CostServices/indian-tribes. For questions 

regarding the indirect cost policy, please 

call the Grants Management Specialist 

listed under ‘‘Agency Contacts’’ or the 

main DGM office at (301) 443–5204. 

4. Reporting Requirements 

The grantee must submit required 

reports consistent with the applicable 

deadlines. Failure to submit required 

reports within the time allowed may 

result in suspension or termination of 

an active grant, withholding of 

additional awards for the project, or 

other enforcement actions such as 

withholding of payments or converting 

to the reimbursement method of 

payment. Continued failure to submit 

required reports may result in one or 

both of the following: (1) The 

imposition of special award provisions; 

and (2) the non-funding or non-award of 

other eligible projects or activities. This 

requirement applies whether the 

delinquency is attributable to the failure 

of the grantee organization or the 

individual responsible for preparation 

of the reports. Per DGM policy, all 

reports are required to be submitted 

electronically by attaching them as a 

‘‘Grant Note’’ in GrantSolutions. 

Personnel responsible for submitting 

reports will be required to obtain a login 

and password for GrantSolutions. Please 

see the Agency Contacts list in section 

VII for the systems contact information. 

The reporting requirements for this 

program are noted below. 

A. Progress Reports 

Program progress reports are required 

to be submitted annually, within 30 

days after the budget period ends. 

Progress reports will include a set of 

standard questions that will be provided 

to each grantee. Additional information 

for reporting and associated 

requirements will be in the 

‘‘Programmatic Terms and Conditions’’ 

in the official Notice of Award, if 

funded. 

A final program progress report must 

be submitted within 90 days of 

expiration of the budget/project period 

at the end of the grant funding cycle. 

B. Financial Reports 

Federal Financial Report (FFR or SF– 

425), Cash Transaction Reports are due 

30 days after the close of every calendar 

quarter to the Payment Management 

Services, HHS at https://pms.psc.gov. It 

is recommended that the applicant also 

send a copy of the FFR (SF–425) report 

to the Grants Management Specialist. 

Failure to submit timely reports may 

cause a disruption in timely payments 

to the organization. 

Grantees are responsible and 

accountable for accurate information 

being reported on all required reports: 

The Progress Reports and Federal 

Financial Report. 

C. Federal Sub-Award Reporting System 

(FSRS) 

This award may be subject to the 

Transparency Act sub-award and 

executive compensation reporting 

requirements of 2 CFR part 170. 

The Transparency Act requires the 

OMB to establish a single searchable 

database, accessible to the public, with 

information on financial assistance 

awards made by Federal agencies. The 

Transparency Act also includes a 

requirement for recipients of Federal 

grants to report information about firsttier sub-awards and executive 

compensation under Federal assistance 

awards. 

IHS has implemented a Term of 

Award into all IHS Standard Terms and 

Conditions, Notice of Funding 

Opportunities and funding 

announcements regarding the FSRS 

reporting requirement. This IHS Term of 

Award is applicable to all IHS grant and 

cooperative agreements issued on or 

after October 1, 2010, with a $25,000 

sub-award obligation dollar threshold 

met for any specific reporting period. 

Additionally, all new (discretionary) 

IHS awards (where the project period is 

made up of more than one budget 

period) and where: (1) The project 

period start date was October 1, 2010 or 

after and (2) the primary awardee will 

have a $25,000 sub-award obligation 

dollar threshold during any specific 

reporting period will be required to 

address the FSRS reporting. 

For the full IHS award term 

implementing this requirement and 

additional award applicability 

information, visit the DGM Grants 

Policy Web site at: http://www.ihs.gov/ 

dgm/policytopics/. 

D. Compliance With Executive Order 

13166 Implementation of Services 

Accessibility Provisions for All Grant 

Application Packages and Funding 

Opportunity Announcements 

Recipients of federal financial 

assistance (FFA) from HHS must 

administer their programs in 

compliance with federal civil rights law. 

This means that recipients of HHS funds 

must ensure equal access to their 

programs without regard to a person’s 

race, color, national origin, disability, 

age and, in some circumstances, sex and 

religion. This includes ensuring your 

programs are accessible to persons with 

limited English proficiency. HHS 

provides guidance to recipients of FFA 

on meeting their legal obligation to take 

reasonable steps to provide meaningful 

access to their programs by persons with 

limited English proficiency. Please see 

http://www.hhs.gov/civil-rights/forindividuals/special-topics/limitedenglish-proficiency/guidance-federalfinancial-assistance-recipients-title-VI/. 

The HHS Office for Civil Rights (OCR) 

also provides guidance on complying 

with civil rights laws enforced by HHS. 

Please see http://www.hhs.gov/civilrights/for-individuals/section-1557/ 

index.html; and http://www.hhs.gov/ 

civil-rights/index.html. Recipients of 

FFA also have specific legal obligations 

for serving qualified individuals with 

disabilities. Please see http://

www.hhs.gov/civil-rights/forindividuals/disability/index.html. 

Please contact the HHS OCR for more 

information about obligations and 

prohibitions under federal civil rights 

laws at https://www.hhs.gov/civil-rights/ 

index.html or call 1–800–368–1019 or 

TDD 1–800–537–7697. Also note it is an 

HHS Departmental goal to ensure access 

to quality, culturally competent care, 

including long-term services and 

supports, for vulnerable populations. 

For further guidance on providing 

culturally and linguistically appropriate 

services, recipients should review the 

National Standards for Culturally and 

Linguistically Appropriate Services in 

Health and Health Care at http://

minorityhealth.hhs.gov/omh/ 

browse.aspx?lvl=2&lvlid=53. 

Pursuant to 45 CFR 80.3(d), an 

individual shall not be deemed 

subjected to discrimination by reason of 

his/her exclusion from benefits limited 

by federal law to individuals eligible for 

benefits and services from the IHS. 

Recipients will be required to sign the 

HHS–690 Assurance of Compliance 

form which can be obtained from the 

following Web site: http://www.hhs.gov/ 

sites/default/files/forms/hhs-690.pdf, 

and send it directly to the: U.S. 

Department of Health and Human 

Services, Office of Civil Rights, 200 

Independence Ave. SW., Washington, 

DC 20201. 

E. Federal Awardee Performance and 

Integrity Information System (FAPIIS) 

The IHS is required to review and 

consider any information about the 

applicant that is in the Federal Awardee 

Performance and Integrity Information 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 37877 

System (FAPIIS) before making any 

award in excess of the simplified 

acquisition threshold (currently 

$150,000) over the period of 

performance. An applicant may review 

and comment on any information about 

itself that a federal awarding agency 

previously entered. IHS will consider 

any comments by the applicant, in 

addition to other information in FAPIIS 

in making a judgment about the 

applicant’s integrity, business ethics, 

and record of performance under federal 

awards when completing the review of 

risk posed by applicants as described in 

45 CFR 75.205. 

As required by 45 CFR part 75 

Appendix XII of the Uniform Guidance, 

non-federal entities (NFEs) are required 

to disclose in FAPIIS any information 

about criminal, civil, and administrative 

proceedings, and/or affirm that there is 

no new information to provide. This 

applies to NFEs that receive federal 

awards (currently active grants, 

cooperative agreements, and 

procurement contracts) greater than 

$10,000,000 for any period of time 

during the period of performance of an 

award/project. 

Mandatory Disclosure Requirements 

As required by 2 CFR part 200 of the 

Uniform Guidance, and the HHS 

implementing regulations at 45 CFR part 

75, effective January 1, 2016, the IHS 

must require a non-federal entity or an 

applicant for a federal award to disclose, 

in a timely manner, in writing to the 

IHS or pass-through entity all violations 

of federal criminal law involving fraud, 

bribery, or gratuity violations 

potentially affecting the federal award. 

Submission is required for all 

applicants and recipients, in writing, to 

the IHS and to the HHS Office of 

Inspector General all information 

related to violations of federal criminal 

law involving fraud, bribery, or gratuity 

violations potentially affecting the 

federal award. 45 CFR 75.113. 

Disclosures must be sent in writing to: 

U.S. Department of Health and 

Human Services, Indian Health Service, 

Division of Grants Management, ATTN: 

Robert Tarwater, Director, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857 (Include ‘‘Mandatory Grant 

Disclosures’’ in subject line), Office: 

(301) 443–5204, Fax: (301) 594–0899, 

Email: Robert.Tarwater@ihs.gov. 

AND 

U.S. Department of Health and 

Human Services, Office of Inspector 

General, ATTN: Mandatory Grant 

Disclosures, Intake Coordinator, 330 

Independence Avenue SW., Cohen 

Building, Room 5527, Washington, DC 

20201, URL: http://oig.hhs.gov/fraud/ 

report-fraud/index.asp (Include 

‘‘Mandatory Grant Disclosures’’ in 

subject line), Fax: (202) 205–0604 

(Include ‘‘Mandatory Grant Disclosures’’ 

in subject line) or Email: 

MandatoryGranteeDisclosures@

oig.hhs.gov. 

Failure to make required disclosures 

can result in any of the remedies 

described in 45 CFR 75.371 Remedies 

for noncompliance, including 

suspension or debarment (See 2 CFR 

parts 180 & 376 and 31 U.S.C. 3321). 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: Miranda 

Carman, Public Health Advisor, Mental 

Health Lead, Division of Behavioral 

Health, 5600 Fishers Lane, Mail Stop 

08N34A, Rockville, MD 20857, Phone: 

(301) 443–2038, Fax: (301) 594–6213, 

Email: Miranda.Carman@ihs.gov. 

2. Questions on grants management 

and fiscal matters may be directed to: 

Willis Grant, Senior Grants Management 

Specialist, 5600 Fishers Lane, Mail 

Stop: 09E70, Rockville, MD 20857, 

Phone: (301) 443–5204, Fax: (301) 594– 

0899, Email: Willis.Grant@ihs.gov. 

3. Questions on systems matters may 

be directed to: Paul Gettys, Grant 

Systems Coordinator, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, MD 

20857, Phone: (301) 443–2114; or the 

DGM main line (301) 443–5204, Fax: 

(301) 594–0899, Email: Paul.Gettys@

ihs.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all cooperative agreement 

and contract recipients to provide a 

smoke-free workplace and promote the 

non-use of all tobacco products. In 

addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking 

in certain facilities (or in some cases, 

any portion of the facility) in which 

regular or routine education, library, 

day care, health care, or early childhood 

development services are provided to 

children. This is consistent with the 

HHS mission to protect and advance the 

physical and mental health of the 

American people. 

Dated: August 8, 2017. 

Michael D. Weahkee, 

Assistant Surgeon General, U.S. Public Health 

Service, Acting Director, Indian Health 

Service. 

[FR Doc. 2017–17103 Filed 8–11–17; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Preventing Alcohol-Related Deaths 

(PARD) Through Social Detoxification 

Announcement Type: New. 

Funding Announcement Number: 

HHS–2017–IHS–PARD–0001. 

Catalog of Federal Domestic 

Assistance Number: 93.933. 

Key Dates 

Application Deadline Date: 

September 16, 2017. 

Review Date: September 18, 2017. 

Earliest Anticipated Start Date: 

September 30, 2017. 

Signed Tribal Resolutions Due Date: 

September 16, 2017. 

Proof of Non-Profit Status Due Date: 

September 16, 2017. 

I. Funding Opportunity Description 

Statutory Authority 

The Indian Health Service (IHS) 

Office of Clinical and Preventive 

Services’ Division of Behavioral Health 

is accepting applications for cooperative 

agreements for Preventing AlcoholRelated Deaths (PARD) through Social 

Detoxification. This program is 

authorized under: Snyder Act, 25 U.S.C. 

13; Consolidated Appropriations Act of 

2017, Public Law 115–31, 131 Stat. 135 

(2017); and 25 U.S.C. 1665a. This 

program is described in the Catalog of 

Federal Domestic Assistance (CFDA) 

under 93.933. 

Background 

Alcohol-related deaths are 520 

percent greater among the American 

Indian and Alaska Native (AI/AN) 

population than the general United 

States population (IHS Trends in Indian 

Health, 2014). Providing social 

detoxification services is often a first 

step toward recovery for individuals 

with an alcohol use disorder to 

minimize physical harm, including 

death. Detoxification alone is not 

sufficient treatment for alcohol use 

disorder but is part of the continuum of 

care that fosters an individual’s entry 

into treatment and rehabilitation. 

Alcohol use disorders are brain 

disorders and not evidence of moral 

weakness. All individuals with alcohol 

use disorders should be treated with 

respect and dignity at all times, in a 

nonjudgmental and supportive manner. 

Services should be completed in 

partnership with the individual and his 

or her social support network with due 

consideration for individual 

background, culture, preferences, 


sradovich on DSK3GMQ082PROD with NOTICES